Human Adenovirus Associated Hepatic Injury
Authors:
Open Access
- 28 April 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10, 878161
Abstract
Human adenovirus (HAdV) is a common virus, but the infections it causes are relatively uncommon. At the same time, the methods for the detection of HAdV are varied, among which viral culture is still the gold standard. HAdV infection is usually self-limited but can also cause clinically symptomatic in lots of organs and tissues, of which human adenovirus pneumonia is the most common. In contrast, human adenovirus hepatitis is rarely reported. However, HAdV hepatitis has a high fatality rate once it occurs, especially in immunocompromised patients. Although human adenovirus hepatitis has some pathological and imaging features, its clinical symptoms are not typical. Therefore, HAdV hepatitis is not easy to be found in the clinic. There are kinds of treatments to treat this disease, but few are absolutely effective. In view of the above reasons, HAdV hepatitis is a disease that is difficult to be found in time. We reviewed and summarized the previously reported cases, hoping to bring some relatively common characteristics to clinicians, so as to facilitate early detection, early diagnosis, and early treatment of patients.Keywords
Funding Information
- Chinese Foundation for Hepatitis Prevention and Control (31010303010946)
This publication has 98 references indexed in Scilit:
- Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenovirusesJournal of Controlled Release, 2012
- Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised PatientsTransplantation and Cellular Therapy, 2012
- Natural killer cells act as rheostats modulating antiviral T cellsNature, 2011
- Crystal Structure of Human Adenovirus at 3.5 Å ResolutionScience, 2010
- Virus Binding to a Plasma Membrane Receptor Triggers Interleukin-1α-Mediated Proinflammatory Macrophage Response In VivoImmunity, 2009
- Insights into adenovirus host cell interactions from structural studiesVirology, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivoProceedings of the National Academy of Sciences, 2008
- Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantationBritish Journal of Haematology, 2006
- The impact of adenovirus infection on the immunocompromised hostReviews in Medical Virology, 2003